MENU
APGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apogee Therapeutics (APGE) Ownership - Who owns Apogee Therapeutics?
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more
Profile
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.2B
P/E Ratio
N/A
Total Cash
513.33M
Projected Growth
N/A
Total Debt
11.82M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.80
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APGE
Capitalization
2.2B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
513M
Total Cash/Share
8.80
Total Debt
11.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
673M
P/B Ratio
3.27
Cash Flow
N/A
Earnings
-3.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
15.82
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-241.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.71
Shares Held By Institutions
3.5B
Shares Outstanding - Current
58.3M
Total Liabilities
40.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-16.667
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com